Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (11): 1164-1170.doi: 10.3969/j.issn.1000-6621.2021.11.011
• Original Articles • Previous Articles Next Articles
XU Zu-hui, LIU Li-qin, WANG Qiao-zhi, XU Sheng-hui, BAI Li-qiong()
Received:
2021-07-13
Online:
2021-11-10
Published:
2021-11-02
Contact:
BAI Li-qiong
E-mail:liqiong99@126.com
XU Zu-hui, LIU Li-qin, WANG Qiao-zhi, XU Sheng-hui, BAI Li-qiong. Study on epidemiological characteristics and influencing factors of pathogen positive hospitalized pulmonary tuberculosis patients with extrapulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1164-1170. doi: 10.3969/j.issn.1000-6621.2021.11.011
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.11.011
特征 | 所有患者 (2532例) | 并发肺外结核 (574例) | 未并发肺外结核 (1958例) | χ2值 | P值 | |||
---|---|---|---|---|---|---|---|---|
性别 | 0.918 | 0.460 | ||||||
男性 | 1771 | 403(22.8) | 1368(77.2) | |||||
女性 | 761 | 171(22.5) | 590(77.5) | |||||
年龄组(岁) | 51.731a | <0.001 | ||||||
6~19 | 129 | 42(32.6) | 87(67.4) | |||||
20~39 | 695 | 216(31.1) | 479(68.9) | |||||
40~59 | 991 | 201(20.3) | 790(79.7) | |||||
60~90 | 717 | 115(16.0) | 602(84.0) | |||||
职业 | 16.210 | 0.001 | ||||||
农民 | 1539 | 312(20.3) | 1227(79.7) | |||||
城市工作者 | 595 | 147(24.7) | 448(75.3) | |||||
学生 | 132 | 42(31.8) | 90(68.2) | |||||
无业或其他 | 266 | 73(27.4) | 193(72.6) | |||||
现住址 | 2.467 | 0.122 | ||||||
长沙 | 559 | 113(20.2) | 446(79.8) | |||||
长沙市外 | 1973 | 461(23.4) | 1512(76.6) | |||||
婚姻状况 | 14.282 | <0.001 | ||||||
已婚 | 2064 | 437(21.2) | 1627(78.8) | |||||
未婚/离异/丧偶 | 468 | 137(29.3) | 331(70.7) | |||||
吸烟 | 0.231 | 0.633 | ||||||
是 | 1125 | 250(22.2) | 875(77.8) | |||||
否 | 1407 | 324(23.0) | 1083(77.0) | |||||
饮酒 | 0.003 | 0.953 | ||||||
是 | 501 | 114(22.8) | 387(77.2) | |||||
否 | 2031 | 460(22.6) | 1571(77.4) | |||||
治疗史 | 0.494 | 0.516 | ||||||
初治 | 1877 | 432(23.0) | 1445(77.0) | |||||
复治 | 655 | 142(21.7) | 513(78.3) | |||||
特征 | 所有患者 (2532例) | 并发肺外结核 (574例) | 未并发肺外结核 (1958例) | χ2值 | P值 | |||
痰涂片 | 1.278 | 0.269 | ||||||
阳性 | 1470 | 345(23.5) | 1125(76.5) | |||||
阴性或未查 | 1062 | 229(21.6) | 833(78.4) | |||||
血行播散性肺结核 | 30.784 | <0.001 | ||||||
是 | 36 | 22(61.1) | 14(38.9) | |||||
否 | 2496 | 552(22.1) | 1944(77.9) | |||||
糖尿病 | 18.202 | <0.001 | ||||||
是 | 416 | 61(14.7) | 355(85.3) | |||||
否 | 2116 | 513(24.2) | 1603(75.8) | |||||
利福平耐药 | 1.409 | 0.253 | ||||||
是 | 425 | 87(20.5) | 338(79.5) | |||||
否 | 2107 | 487(23.1) | 1620(76.9) |
肺外结核侵犯部位 | 侵犯 频次a | 并发率 (%)b | 构成比 (%)c |
---|---|---|---|
淋巴系统 | 341 | 13.5 | 48.0 |
颈部 | 306 | 12.1 | 43.0 |
纵隔 | 28 | 1.1 | 3.9 |
腋下 | 7 | 0.3 | 1.0 |
头部及五官 | 115 | 4.5 | 16.2 |
脑膜 | 14 | 0.6 | 2.0 |
咽喉 | 98 | 3.9 | 13.8 |
耳 | 2 | 0.1 | 0.3 |
舌部 | 1 | 0.0 | 0.1 |
消化系统 | 105 | 4.1 | 14.8 |
腹部(腹腔、腹膜) | 65 | 2.6 | 9.1 |
肠 | 33 | 1.3 | 4.6 |
肝、脾 | 6 | 0.2 | 0.8 |
肛周 | 1 | 0.0 | 0.1 |
循环系统 | 62 | 2.4 | 8.7 |
心包 | 62 | 2.4 | 8.7 |
运动系统 | 56 | 2.2 | 7.9 |
脊柱 | 31 | 1.2 | 4.4 |
骨、关节 | 25 | 1.0 | 3.5 |
泌尿生殖系统 | 32 | 1.3 | 4.5 |
泌尿系统(肾、肾上腺、膀胱) | 13 | 0.5 | 1.8 |
盆腔 | 10 | 0.4 | 1.4 |
男性生殖系统(睾丸、附睾) | 7 | 0.3 | 1.0 |
乳腺、子宫 | 2 | 0.1 | 0.3 |
合计 | 711 | 28.1 | 100.0 |
变量 | β值 | s | Wald χ2值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
年龄组(岁) | |||||
6~19 | 0.972 | 0.303 | 10.324 | 0.001 | 2.64(1.46~4.78) |
20~39 | 0.843 | 0.151 | 31.290 | <0.001 | 2.32(1.73~3.12) |
40~59 | 0.352 | 0.133 | 7.064 | 0.008 | 1.42(1.10~1.85) |
60~90 | - | - | - | - | 1 |
痰涂片 | |||||
阳性 | 0.255 | 0.103 | 6.141 | 0.013 | 1.29(1.05~1.58) |
阴性或未检 | - | - | - | - | 1 |
血行播散性肺结核 | |||||
是 | 1.776 | 0.356 | 24.904 | <0.001 | 5.91(2.94~11.86) |
否 | - | - | - | - | 1 |
糖尿病 | |||||
无 | -0.489 | 0.155 | 9.944 | 0.002 | 1.64(1.20~2.22) |
有 | - | - | - | - | 1 |
[1] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 2017-11-09. |
[2] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[3] |
刘二勇, 李玉红, 周林, 等. 统筹兼顾: 肺外结核应纳入防治规划. 中国防痨杂志, 2021, 43(5):428-431. doi: 10.3969/j.issn.1000-6621.2021.05.003.
doi: 10.3969/j.issn.1000-6621.2021.05.003 |
[4] |
杨松, 王乐乐, 李同心, 等. 肺外结核流行病学研究进展. 中华流行病学杂志, 2021, 42(1):171-176. doi: 10.3760/cma.j.cn112338-20200814-01067.
doi: 10.3760/cma.j.cn112338-20200814-01067 |
[5] | 唐神结, 高文. 临床结核病学. 2版. 北京: 人民卫生出版社, 2019: 100-120. |
[6] |
于佳佳, 李亮, 杜建, 等. 肺结核住院患者并发肺外结核状况及其与性别和年龄相关性的多中心研究. 中国防痨杂志, 2020, 42(6):563-569. doi: 10.3969/j.issn.1000-6621.2020.06.006.
doi: 10.3969/j.issn.1000-6621.2020.06.006 |
[7] |
Pang Y, An J, Shu W, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008—2017. Emerg Infect Dis, 2019, 25(3):457-464. doi: 10.3201/eid2503.180572.
doi: 10.3201/eid2503.180572 |
[8] |
陈继川, 姬长友, 刘兆华. 咽喉结核的流行病学和临床变迁. 临床耳鼻咽喉科杂志, 2003, 17(6):379-381. doi: 10.3969/j.issn.1001-1781.2003.06.035.
doi: 10.3969/j.issn.1001-1781.2003.06.035 |
[9] |
丁滨, 陈晓红. 2004—2013年耳鼻咽喉疾病中国误诊大数据概要分析. 临床耳鼻咽喉头颈外科杂志, 2016, 30(15):1195-1200. doi: 10.13201/j.issn.1001-1781.2016.15.005.
doi: 10.13201/j.issn.1001-1781.2016.15.005 |
[10] |
黄建生, 沈梅, 孙亚玲. 上海市肺外结核的流行病学分析. 中华结核和呼吸杂志, 2000, 23(10):606. doi: 10.3760/j:issn:1001-0939.2000.10.009.
doi: 10.3760/j:issn:1001-0939.2000.10.009 |
[11] |
陈素婷, 付育红, 赵立平, 等. 肺结核并发各种类型肺外结核患者的分布及其耐药情况分析. 中国防痨杂志, 2018, 40(9):964-968. doi: 10.3969/j.issn.1000-6621.2018.09.011.
doi: 10.3969/j.issn.1000-6621.2018.09.011 |
[12] |
肖娟, 皮红林, 孙庆鹏. 96例行手术治疗的脊柱结核患者临床特征及治疗效果分析. 结核与肺部疾病杂志, 2021, 2(1):38-42. doi: 10.3969/j.issn.2096-8493.2021.01.009.
doi: 10.3969/j.issn.2096-8493.2021.01.009 |
[13] |
Kang W, Yu J, Du J, et al. The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study. PLoS One, 2020, 15(8):e0237753. doi: 10.1371/journal.pone.0237753.
doi: 10.1371/journal.pone.0237753 |
[14] |
宁锋钢, 周新华, 侯代伦, 等. 成年血行播散性肺结核并发颅内结核的临床及头颅MRI表现特征. 中国防痨杂志, 2020, 42(1):19-25. doi: 10.3969/j.issn.1000-6621.2020.01.007.
doi: 10.3969/j.issn.1000-6621.2020.01.007 |
[15] |
杨铭, 袁平, 王燕, 等. 四川地区502例血行播散性肺结核临床患病情况分析. 四川医学, 2018, 39(9):977-982. doi: 10.16252/j.cnki.issn1004-0501-2018.09.002.
doi: 10.16252/j.cnki.issn1004-0501-2018.09.002 |
[16] |
马建军, 袁燕莉, 张铁娟. 基于Web of Science数据库的结核病并发糖尿病研究引文可视化分析. 结核病与肺部健康杂志, 2018, 7(3):198-204. doi: 10.3969/j.issn.2095-3755.2018.03.011.
doi: 10.3969/j.issn.2095-3755.2018.03.011 |
[17] | Lin JN, Lai CH, Chen YH, et al. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis, 2009, 13:620-625. |
[18] |
Gomes T, Reis-Santos B, Bertolde A, et al. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect Dis, 2014, 14:9. doi: 10.1186/1471-2334-14-9.
doi: 10.1186/1471-2334-14-9 |
[19] |
Magee MJ, Foote M, Ray SM, et al. Diabetes mellitus and extrapulmonary tuberculosis: site distribution and risk of mortality. Epidemiol Infect, 2016, 144(10):2209-2216. doi: 10.1017/S0950268816000364.
doi: 10.1017/S0950268816000364 |
[20] |
Korma W, Mihret A, Hussien J, et al. Clinical, molecular and drug sensitivity pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases in Addis Ababa, Ethiopia. BMC Infect Dis, 2015, 15:456. doi: 10.1186/s12879-015-1177-4.
doi: 10.1186/s12879-015-1177-4 |
[21] |
王冬梅, 李青峰, 朱玛, 等. 成都地区6107例肺外结核患者结核分枝杆菌感染与耐药情况. 中华结核和呼吸杂志, 2017, 40(8):592-595. doi: 10.3760/cma.j.issn.1001-0939.2017.08.010.
doi: 10.3760/cma.j.issn.1001-0939.2017.08.010 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||